LOC102723536: A Protein of Interest in the Brain (G102723536)

LOC102723536: A Protein of Interest in the Brain

LOC102723536 is a protein that is found in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the LOC102723536 family, which is characterized by the presence of a unique transmembrane domain and a cytoplasmic tail. While LOC102723536 is not a well-studied protein in its own right, research into its variants and potential functions as a drug target is ongoing.

The LOC102723536 protein is a transcript variant, which means that it is a variant form of a gene that has been transcribed from DNA to RNA. There are several different transcript variants of the LOC102723536 gene, each with a unique amino acid sequence. One of these variants, known as X2, has been shown to have altered stability and stability in the brain, which could make it a potential drug target.

Research into LOC102723536 has been primarily focused on its role in the brain, where it is known to be involved in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. Synaptic plasticity is an important aspect of brain development and function, and LOC102723536 is thought to play a role in the formation and maintenance of neural connections in the brain.

One of the key features of LOC102723536 is its cytoplasmic tail, which is a region of the protein that extends beyond the membrane of the cell and into the cytoplasm. This tail is thought to be involved in the regulation of the stability and localization of the protein, as well as its interactions with other proteins and molecules.

While more research is needed to fully understand the role of LOC102723536 in the brain, its potential as a drug target is being investigated. One approach being explored is the use of small molecules to modulate the stability and localization of the protein, with the goal of increasing its levels in certain tissues and reducing its levels in others. This approach could be used to treat a variety of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression.

Another potential approach to targeting LOC102723536 is to use it as a biomarker, or a protein that is used as a indicator of the presence or absence of a particular disease or condition. This approach could be used to diagnose and monitor a variety of diseases, including neurodegenerative disorders, psychiatric disorders, and cancer.

While more research is needed to fully understand the role of LOC102723536 in the brain and its potential as a drug target or biomarker, it is clear that this protein is of great interest and continues to be the subject of active research. As the understanding of its role in the brain deepens, it will be exciting to see how this protein continues to evolve and contribute to the understanding of complex neurological and psychiatric disorders.

In conclusion, LOC102723536 is a protein that is being studied for its potential role in the regulation of synaptic plasticity and its impact on the brain. While more research is needed to fully understand its function, its potential as a drug target or biomarker is being investigated, and its role in the development and treatment of neurological and psychiatric disorders is being actively explored. With continued research, it is possible that LOC102723536 will emerge as a valuable tool for the treatment of a variety of conditions that are currently underserved by effective therapies.

Protein Name: Uncharacterized LOC102723536

The "LOC102723536 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC102723536 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC102723553 | LOC102723560 | LOC102723564 | LOC102723566 | LOC102723568 | LOC102723576 | LOC102723596 | LOC102723639 | LOC102723686 | LOC102723692 | LOC102723724 | LOC102723739 | LOC102723750 | LOC102723769 | LOC102723834 | LOC102723838 | LOC102723850 | LOC102723878 | LOC102723890 | LOC102723906 | LOC102723911 | LOC102723914 | LOC102723944 | LOC102723961 | LOC102724001 | LOC102724012 | LOC102724019 | LOC102724023 | LOC102724034 | LOC102724036 | LOC102724058 | LOC102724080 | LOC102724081 | LOC102724087 | LOC102724104 | LOC102724122 | LOC102724137 | LOC102724142 | LOC102724145 | LOC102724192 | LOC102724229 | LOC102724288 | LOC102724322 | LOC102724355 | LOC102724428 | LOC102724429 | LOC102724434 | LOC102724438 | LOC102724467 | LOC102724497 | LOC102724511 | LOC102724520 | LOC102724527 | LOC102724528 | LOC102724542 | LOC102724551 | LOC102724572 | LOC102724594 | LOC102724632 | LOC102724642 | LOC102724653 | LOC102724682 | LOC102724684 | LOC102724719 | LOC102724748 | LOC102724761 | LOC102724768 | LOC102724778 | LOC102724785 | LOC102724786 | LOC102724790 | LOC102724802 | LOC102724808 | LOC102724849 | LOC102724889 | LOC102724900 | LOC102724929 | LOC102724934 | LOC102724945 | LOC102724948 | LOC102724968 | LOC102724977 | LOC102725019 | LOC102725030 | LOC102725038 | LOC102725065 | LOC102725112 | LOC102725148 | LOC102725159 | LOC102725238 | LOC103171574 | LOC104054148 | LOC105369160 | LOC105369165 | LOC105369166 | LOC105369167 | LOC105369194 | LOC105369197 | LOC105369209 | LOC105369212